Detection of riddelliine-derived DNA adducts in blood of rats fedriddelliine

International Journal of Molecular Sciences

Volumn 3, Issue 9, 2002, Pages 1019-1026

  Yan, Jian ^a   Nichols, Jasyl ^a   Yang, Ya Cheng ^b   Fu, Peter P ^a   Chou, Ming W ^a  

^a NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

^b FOOYIN UNIVERSITY   (Taiwan)

Author keywords

Dehydroretronecine; Pyrrolizidine alkaloids; Rat blood DNA adducts; Riddelliine

Indexed keywords

6,7 DIHYDRO 7 HYDROXY 1 HYDROXYMETHYL 5H PYRROLIZINE; BIOLOGICAL MARKER; NUCLEOTIDE; PYRROLIZIDINE ALKALOID; PYRROLIZINE DERIVATIVE; RIDDELLINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BLOOD CELL; CHEMICAL STRUCTURE; CONTROLLED STUDY; DNA ADDUCT; DNA DETERMINATION; DNA ISOLATION; DOSE RESPONSE; EXPOSURE; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LEUKOCYTE; LIVER LEVEL; MALE; METABOLIC ACTIVATION; NONHUMAN; RAT; SINGLE DRUG DOSE;

ANIMALIA;

EID: 0141685700     PISSN: 14220067     EISSN: None     Source Type: Journal    
DOI: 10.3390/i3091019     Document Type: Article

References (19)

1. Molyneux, R. J.; Johnson, A. E.; Roitman, J. N.; Benson, M. E. J. Agric. Food Chem. 1979, 27, 494.
2. Mattocks, A. R. Chemistry and Toxicology of Pyrrolizidine Alkaloids, Academic Press, New York, 1986.
3. International Agency for Research on Cancer (IARC) Pyrrolizidine alkaloids. In IARC Monograph on the Evaluation of Carcinogenic Risk of Chemicals to Man - Some Naturally Occurring Substance. 10, pp 265-342, International Agency for Research on Cancer, Lyon, France, 1976.
4. Fu, P. P.; Chou, M. W.; Xia, Q.; Yang, Y.-C.; Yan, J.; Dorege, D. R.; Chan, P. C. Environ. Carcinogen Ecotoxicol. Rev. 2001, C19 (2), 353.
5. Chan, P. C.; Mahler, J.; Bucher, J. R.; Travelos, G. S.; Reid, J. B. Toxicon 1994, 32, 891.
6. 1 Mice, NIH Publication No. 94-3350, 1993.
7. 1 Mice. NTP TR 508, NIH Publication No. 01-4442, 2001.
8. World Health Organization (WHO) Pyrrolizidine Alkaloids. In International Programme on Chemical Safety, Environmental Health Criteria. 80, p 337, World Health Organization, Geneva, 1988.
9. Huxtable, R. J. Perspect. Biol. Med. 1980, 24, 1.
10. Mattocks, A. R.; Cabral, J. R. Cancer Lett. 1982, 17, 61.
11. Yang, Y.-C.; Yan J.; Doerge, D. R.; Chan, P.-C.; Fu P. P.; Chou, M. W. Chem. Res. Toxicol. 2001, 14, 101.
12. Mattocks, A. R.; White, I. N. Chem. Biol. Interact. 1971, 3, 383.
13. Dueker, S. R.; Lame, M. W.; Morin, D.; Wilson, D. W.; Segall, H. J. Drug Metab. Dispos. 1992, 20, 275.
14. Yang, Y.-C.; Yan, J.; Churchwell, M.; Beger, R.; Chan, P.-C.; Doerge, D. R.; Fu, P. P.; M. W. Chou. Chem. Res. Toxicol. 2001, 14, 91.
15. Kedzierski, B.; Buhler, D. R. Toxicol. Lett. 1985, 25, 115.
16. Yan, J.; Yang Y.-C.; Williams, L.; Xia, Q.; Doerge, D. R.; Chou, M. W.; Fu, P. P. Development of an alternative strategy for detection of carcinogen-modified DNA adducts in vitro and in vivo by 32P-postlabeling/HPLC. 220th ACS National Meeting, Chicago, IL. 2001.
17. Williams, L. D.; Chou, M. W.; Yan, J.; Young, J. F.; Chan, P. C.; and Doerge, D. R. Toxicol. Appl. Pharmacol. 2002, 182, 98.
18. Pan, L. C.; Lame, M. W.; Morin, D.; Wilson, D. W.; Segall, H. J. Toxicol Appl. Pharmacol. 1991, 110, 336.
19. Estep, J. E.; Lame, M. W.; Morin, D.; Jones, A. D.; Wilson, D. W.; Segall, H. J. Drug Metab. Disps. 1991, 19, 135.